Related Experiment Video
Updated: May 10, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Functional dyspepsia: the economic impact to patients
B E Lacy1, K T Weiser, A T Kennedy
1Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. brian.e.lacy@hitchcock.org
Functional dyspepsia (FD) significantly impacts patients economically, leading to high healthcare utilization and substantial direct and indirect costs. This condition also impairs work productivity, highlighting its considerable economic burden.
Area of Science:
- Gastroenterology
- Health Economics
- Public Health
Background:
- Functional dyspepsia (FD) is a prevalent condition with poorly understood economic consequences.
- Existing research offers limited insight into the financial burden of FD on patients and healthcare systems.
Purpose of the Study:
- To determine the healthcare utilization patterns of patients diagnosed with functional dyspepsia.
- To estimate the direct and indirect economic costs associated with functional dyspepsia for affected individuals.
Main Methods:
- Adult patients with dyspepsia were identified using ICD-9 codes.
- A validated questionnaire was administered to patients meeting Rome III criteria for FD to collect data on healthcare use and costs.
Main Results:
- The study included 355 FD patients, with 52% reporting moderate symptom severity.
- Patients incurred average annual direct costs of $699, including $582 for diagnostic testing.
- Productivity losses were observed, with patients reporting an average of 1.4 hours of work absence in the week prior to the survey.
Conclusions:
- Functional dyspepsia imposes significant direct and indirect financial costs on patients.
- Impaired work productivity is a notable consequence of dyspeptic symptoms, contributing to the overall economic burden of FD.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
